PLGG shares with melanoma a high prevalence of activating mutations in BRAF. Furthermore, overexpression of active BRAF leads to oncogene induced senescence in PLGG29,30, which may be one of the reasons that this disease is difficult to model in the laboratory. This evidence concerns the gene BRAF and melanoma.